Creating Waves of Awareness
Dr. C. Hempel in " A new and comprehensive system of materia medica published in 1864 writes under Tabacum, urinary and sexual symptoms - "We are unable to say how far Tobacco may be of service in the treatment of Diabetes; it is ranked among the diuretics by Old-School practitioners; and a celebrated English authority, Dr. Prout, we think, accuses Tobacco of destroying the saccharine element in the liver; it may therefore be a legitimate inference, from the homoeopathic standing-point, that Tobacco may be useful in the treatment of diabetes insipidus as well as mellitas.
Impotence is one of the effects of Tobacco; hence it may prove very serviceable in Impotence, with absence of sexual desire, brought on by excessive abstemiousness, and more particularly by excessive abuse of such beverages as coffee, and intense mental application.
Now in recent years, scientists are experimenting with tobacco in the treatment of Diabetes as is evident from the following article.
Medicine from Tobacco ?
Tobacco isn`t famous for its health benefits. But now scientists have succeeded in using genetically modified tobacco plants to produce medicines for several autoimmune and inflammatory diseases, including diabetes. The research is published in the open access journal BMC Biotechnology.
A large team of scientists from several European research organizations have participated in the study as part of the PharmaPlanta Project, led by Professor Mario Pezzotti at the university of Verona. Scientists have created transgenic tobacco plants that would produce biologically active interleukin – 10 (IL-10), a potent anti-inflammatory cytokine. They tried two different versions of IL-10 (one from a virus and another from a mouse) and generated plants in which this protein was targeted to three different compartments within the cell to see which would work most effectively.
The researchers found that tobacco plants were able to process both forms of IL-10 correctly, producing the active cytokine at high enough levels. The next step will be to feed these plants to mice with autoimmune diseases to find out how effective they are.
The scientists are keen to use the plants to see whether repeated small doses could prevent type 1 diabetes mellitus, in combination with other auto-antigens associated with the disease.
According to Pezzotti, “ Transgenic plants are attractive systems for the production of therapeutic proteins because they offer the possibility of large scale production of foreign proteins at low cost, and they have low maintenance requirements. The fact that they can be eaten , which delivers the drug where it is needed, thus avoiding lengthy purification procedures, is another advantage compared with traditional drug synthesis”.
Science Reporter, Pp-17 , August 2009.